SELHORN RYAN J (Chief Financial Officer) received a stock award from AYTU BIOPHARMA, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 10/7/2025ACC: 0001437749-25-030645
Officer· Chief Financial Officer
Since Nov 2024
+33.74K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
33.74K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+16.24K
Price / share
—
Trade value
—
% of position
101.5%
10/3/2025
16K→32.24K
Common Stock
Direct
Shares
+17.50K
Price / share
—
Trade value
—
% of position
54.3%
10/3/2025
32.24K→49.74K
Total
Net shares
+33.74K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/3/2025 | A · Award | +16.24K | — | — | 101.5% | 16K | 32.24K |
| Common Stock Direct | 10/3/2025 | A · Award | +17.50K | — | — | 54.3% | 32.24K | 49.74K |
| Total | +33.74K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported